BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37142293)

  • 21. Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.
    Farrell RJ; Ang Y; Kileen P; O'Briain DS; Kelleher D; Keeling PW; Weir DG
    Gut; 2000 Oct; 47(4):514-9. PubMed ID: 10986211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort study.
    Thomsen SB; Ungaro RC; Allin KH; Elmahdi R; Poulsen G; Andersson M; Colombel JF; Jess T
    Aliment Pharmacol Ther; 2022 May; 55(9):1128-1138. PubMed ID: 35080036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low Risk of Lymphoma in Pediatric Patients Treated for Inflammatory Bowel Disease.
    Egberg MD; Zhang X; Smitherman AB; Kappelman MD
    Am J Gastroenterol; 2023 Feb; 118(2):354-359. PubMed ID: 36219181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
    Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of genital warts in inflammatory bowel disease: A Danish registry-based cohort study (1996-2018).
    Elmahdi R; Thomsen LT; Iversen AT; Allin KH; Kjaer SK; Jess T
    United European Gastroenterol J; 2022 Apr; 10(3):287-295. PubMed ID: 35297191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 27. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden.
    Axelrad JE; Olén O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Gut; 2021 Feb; 70(2):297-308. PubMed ID: 32474410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
    Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study.
    Jung YS; Han M; Park S; Kim WH; Cheon JH
    J Crohns Colitis; 2017 Aug; 11(8):954-962. PubMed ID: 28333358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study.
    Kirchgesner J; Nyboe Andersen N; Carrat F; Jess T; Beaugerie L;
    Gut; 2020 May; 69(5):852-858. PubMed ID: 31446428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden.
    Nguyen LH; Örtqvist AK; Cao Y; Simon TG; Roelstraete B; Song M; Joshi AD; Staller K; Chan AT; Khalili H; Olén O; Ludvigsson JF
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):986-995. PubMed ID: 32818437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk factors for lymphoma in a single-center inflammatory bowel disease population.
    Chiorean MV; Pokhrel B; Adabala J; Helper DJ; Johnson CS; Juliar B
    Dig Dis Sci; 2011 May; 56(5):1489-95. PubMed ID: 20953706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory Bowel Diseases Increase Risk of Type 2 Diabetes in a Nationwide Cohort Study.
    Jess T; Jensen BW; Andersson M; Villumsen M; Allin KH
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):881-888.e1. PubMed ID: 31394285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India.
    Ranjan MK; Kante B; Vuyyuru SK; Kumar P; Mundhra SK; Golla R; Sharma R; Sahni P; Das P; Makharia G; Kedia S; Ahuja V
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1544-1553. PubMed ID: 35501287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry.
    Mariette X; Tubach F; Bagheri H; Bardet M; Berthelot JM; Gaudin P; Heresbach D; Martin A; Schaeverbeke T; Salmon D; Lemann M; Hermine O; Raphael M; Ravaud P
    Ann Rheum Dis; 2010 Feb; 69(2):400-8. PubMed ID: 19828563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study.
    Choe YJ; Han K; Shim JO
    Aliment Pharmacol Ther; 2022 Sep; 56(6):980-988. PubMed ID: 35791668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of lymphoid neoplasms in a Swedish population-based cohort of 337,437 patients undergoing appendectomy.
    Mohammadi M; Song H; Cao Y; Glimelius I; Ekbom A; Ye W; Smedby KE
    Scand J Gastroenterol; 2016; 51(5):583-9. PubMed ID: 26652908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
    Wang LH; Yang YJ; Cheng WC; Wang WM; Lin SH; Shieh CC
    Am J Gastroenterol; 2016 Sep; 111(9):1313-9. PubMed ID: 27296944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do inflammatory bowel disease therapies cause cancer?
    Mason M; Siegel CA
    Inflamm Bowel Dis; 2013 May; 19(6):1306-21. PubMed ID: 23470503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.